Proactive Investors - Run By Investors For Investors

New Tissue Regenix CFO to step into role earlier than anticipated

Gareth Jones was supposed to take up his new role at the end of November, but having already completed the handover at his old company, he starts today (Monday)
ribbon being cut
Jones is joining from Applied Graphene Materials

The new chief financial officer of Tissue Regenix Group PLC (LON:TRX) has joined regenerative medical devices company a month earlier than expected.

Gareth Jones’ appointment was first unveiled back in July and he was originally scheduled to take up his new role at the end of November.

READ: Tissue Regenix appoints new CFO

But he has already completed the handover process in his previous position as the chief number cruncher at Applied Graphene Materials PLC (LON:AGM).

“I am delighted to welcome Gareth to the group,” said chief executive Steve Couldwell.

“He will play a pivotal role in the strategic direction, focus and acceleration of our commercial success.

He added: “Utilising his experience and knowledge of both operational and financial enhancement initiatives, alongside his international and listed company experience, we expect Gareth to help execute on our vision and accelerate sustainable long-term shareholder value.”

View full TRX profile View Profile

Tissue Regenix Group PLC Timeline

Related Articles

scientists in a lab
January 30 2019
The technology first drew the attention of ChemioCare CEO Pedro Lichtinger years ago while he oversaw Pfizer's global primary care business
scientist in laboratory
May 24 2019
Here we take a closer look at healthcare investor NetScientific PLC (LON:NSCI)
picture of a knee
May 20 2019
We take a closer look at Collagen Solutions, which received third-party validation of its business model in the form of outside investment from a blue-chip US agriculture company
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use